Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
324.51
270.37
251.51
230.10
212.03
162.21
171.43
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
324.51
270.37
251.51
230.10
212.03
162.21
171.43
Raw Material Cost
126.48
119.53
117.74
105.00
96.02
73.07
74.34
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
61.70
59.99
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.63
0.38
0.19
0.27
0.07
0.10
0.49
Selling and Distribution Expenses
78.49
70.16
67.70
57.68
59.40
45.25
40.33
Other Expenses
4.71
3.38
3.35
-2.87
-3.24
1.37
1.20
Total Expenditure (Excl Depreciation)
252.74
223.91
219.15
195.93
183.13
132.17
127.16
Operating Profit (PBDIT) excl Other Income
71.8
46.5
32.400000000000006
34.2
28.900000000000002
30
44.3
Other Income
15.60
11.08
12.43
10.95
18.38
10.13
4.19
Operating Profit (PBDIT)
100.40
67.76
53.92
52.65
54.05
46.32
53.62
Interest
0.63
0.38
0.19
0.27
0.07
0.10
0.49
Exceptional Items
8.48
-1.89
4.06
2.14
-0.64
0.56
1.03
Gross Profit (PBDT)
198.03
150.84
133.77
125.10
116.01
89.13
97.09
Depreciation
13.08
10.66
9.83
8.44
7.24
6.58
5.56
Profit Before Tax
95.17
54.83
47.95
46.08
46.09
40.20
48.60
Tax
9.98
2.94
0.64
2.89
4.67
5.25
6.59
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
85.19
51.89
47.31
43.20
41.42
34.95
42.01
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
85.19
51.89
47.31
43.20
41.42
34.95
42.01
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
85.19
51.89
47.31
43.20
41.42
34.95
42.01
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
565.55
581.43
571.52
508.41
512.13
465.89
107.18
Earnings per share (EPS)
1.05
0.64
0.58
0.53
0.51
0.44
0.53
Diluted Earnings per share
1.05
0.64
0.58
0.53
0.51
0.44
0.53
Operating Profit Margin (Excl OI)
22.1%
17.02%
12.59%
14.45%
13.41%
18.25%
25.59%
Gross Profit Margin
33.36%
24.22%
22.97%
23.7%
25.15%
28.84%
31.59%
PAT Margin
26.25%
19.19%
18.81%
18.77%
19.53%
21.55%
24.5%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 20.01% vs 7.51% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 64.16% vs 9.73% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 49.56% vs 36.63% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 50.00% vs 100.00% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Touchstone International Medical Science Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
324.51
0
324.51
Other Operating Income
0.00
0.00
0.00
Total Operating income
324.51
0
324.51
Raw Material Cost
126.48
0
126.48
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.63
0
0.63
Selling and Distribution Expenses
78.49
0
78.49
Other Expenses
4.71
0.00
4.71
Total Expenditure (Excl Depreciation)
252.74
0
252.74
Operating Profit (PBDIT) excl Other Income
71.77
0.00
71.77
Other Income
15.60
0
15.60
Operating Profit (PBDIT)
100.40
0
100.40
Interest
0.63
0
0.63
Exceptional Items
8.48
0
8.48
Gross Profit (PBDT)
198.03
0
198.03
Depreciation
13.08
0
13.08
Profit Before Tax
95.17
0
95.17
Tax
9.98
0
9.98
Provisions and contingencies
0
0
0.00
Profit After Tax
85.19
0
85.19
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
85.19
0
85.19
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
85.19
0
85.19
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
565.55
0
565.55
Earnings per share (EPS)
1.05
0
1.05
Diluted Earnings per share
1.05
0
1.05
Operating Profit Margin (Excl OI)
22.10%
0%
0.00
22.10%
Gross Profit Margin
33.36%
0%
0.00
33.36%
PAT Margin
26.25%
0%
0.00
26.25%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 32.45 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 20.01% vs 7.51% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 8.52 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 64.16% vs 9.73% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 8.48 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 49.56% vs 36.63% in Dec 2024
Annual - Interest
Interest 0.06 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 50.00% vs 100.00% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.10%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






